Update on treatment strategies for obesity.
Open Access
- 1 April 2013
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 98 (4), 1299-306
- https://doi.org/10.1210/jc.2012-3115
Abstract
Obesity is a disease that is defined as the accumulation of excessive amounts of body fat and is associated with increased risk of serious illness, disability, and death. In clinical practice, obesity is best assessed by calculating body mass index and measuring waist circumference. Treatment options are determined based on the body mass index, waist circumference, and adverse health consequences the patient is experiencing or is at an increased risk for facing in the future. Today, overweight and obesity impacts the majority of patients we treat in our clinical practices. Although endocrinologists are uniquely positioned to treat one of the major consequences of our current obesity epidemic, type 2 diabetes, we also need to be positioned and prepared to effectively treat one of its major causes-obesity. Type 2 diabetes and obesity are very much intertwined. Treatment of each disease affects the other. For these reasons, endocrinologists need to be experts in the treatment of obesity as well as diabetes. They should keep up with advances in obesity treatment including lifestyle, pharmaceutical, and surgical strategies. These strategies offer opportunities for improving the overall treatment for our obese patients today and will continue to improve and expand over the next decade.Keywords
This publication has 37 references indexed in Scilit:
- Lifestyle Modification for ObesityCirculation, 2012
- Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010JAMA, 2012
- Metabolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duodenal–Jejunal Bypass LinerDiabetes Technology & Therapeutics, 2012
- Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)Obesity, 2012
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension studyThe American Journal of Clinical Nutrition, 2012
- Long-Term Persistence of Hormonal Adaptations to Weight LossThe New England Journal of Medicine, 2011
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM TrialJournal of Clinical Endocrinology & Metabolism, 2011
- Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesityCMAJ : Canadian Medical Association Journal, 2011
- Bariatric surgery: an IDF statement for obese Type 2 diabetesDiabetic Medicine, 2011
- Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: ‘A new kid on the block’?Annals of Medicine, 2011